Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...
HIGHLIGHTS:Cygnus’ common shares have qualified to trade on the OTCQB® Venture Market ('OTCQB'), a U.S. marketplace operated by OTC Markets Group ...
The sketch show’s 50-year history has spawned countless pop culture moments. Sketches like “Wayne’s World” led to entire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback